Monopar Therapeutics Inc.
MNPR
$59.27
-$1.72-2.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 140.40M | 143.68M | 53.25M | 54.55M | 60.21M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 63.70K | 414.80K | 497.30K | 523.60K | 78.90K |
| Total Current Assets | 140.46M | 144.09M | 53.75M | 55.08M | 60.29M |
|
|
|||||
| Total Current Assets | 140.46M | 144.09M | 53.75M | 55.08M | 60.29M |
| Net Property, Plant & Equipment | 254.90K | 106.70K | 118.20K | 9.10K | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 140.72M | 144.20M | 53.87M | 55.09M | 60.29M |
|
|
|||||
| Total Accounts Payable | 2.64M | 2.54M | 1.55M | 1.49M | 2.25M |
| Total Accrued Expenses | -- | -- | -- | -- | 3.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 90.60K | 31.40K | 33.40K | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.74M | 2.57M | 1.58M | 1.49M | 5.25M |
|
|
|||||
| Total Current Liabilities | 2.74M | 2.57M | 1.58M | 1.49M | 5.25M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 154.90K | 70.90K | 80.40K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.89M | 2.64M | 1.66M | 1.49M | 5.25M |
|
|
|||||
| Common Stock & APIC | 227.21M | 225.85M | 133.00M | 132.03M | 130.79M |
| Retained Earnings | -89.51M | -84.31M | -80.87M | -78.42M | -75.79M |
| Treasury Stock & Other | 131.40K | 11.70K | 77.60K | -21.80K | 36.00K |
| Total Common Equity | 137.83M | 141.56M | 52.20M | 53.59M | 55.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 137.83M | 141.56M | 52.20M | 53.59M | 55.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 137.83M | 141.56M | 52.20M | 53.59M | 55.04M |
|
|
|||||